[
    [
        {
            "time": "",
            "original_text": "沃森生物4个月市值蒸发939亿 申万宏源中银等山顶唱多 连续下跌",
            "features": {
                "keywords": [
                    "沃森生物",
                    "市值蒸发",
                    "申万宏源",
                    "中银",
                    "唱多",
                    "连续下跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物4个月市值蒸发939亿 申万宏源中银等山顶唱多 连续下跌",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "年终盘点之疫苗篇：抢占新冠疫苗赛道 药企研发争分夺秒",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "药企",
                    "研发",
                    "争分夺秒"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "年终盘点之疫苗篇：抢占新冠疫苗赛道 药企研发争分夺秒",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "德展健康疫苗代理布局再获进展，旗下首惠医药代理的国光流感疫苗开始放量",
            "features": {
                "keywords": [
                    "德展健康",
                    "疫苗代理",
                    "国光流感疫苗",
                    "放量"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "德展健康疫苗代理布局再获进展，旗下首惠医药代理的国光流感疫苗开始放量",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]